Aralez Pharmaceuticals Inc (TSE:ARZ)’s share price traded down 5.5% on Wednesday . The stock traded as low as C$1.82 and last traded at C$1.92. 8,579 shares changed hands during trading, a decline of 80% from the average session volume of 42,235 shares. The stock had previously closed at C$1.82.

WARNING: “Aralez Pharmaceuticals (ARZ) Stock Price Down 5.5%” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/12/13/aralez-pharmaceuticals-arz-stock-price-down-5-5.html.

Aralez Pharmaceuticals Company Profile

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Stock Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related stocks with our FREE daily email newsletter.